Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Pro Medicus Limited ( (AU:PME) ).
Pro Medicus Limited has announced that it will release its half-year 2026 financial results on Thursday, 12 February 2026, underscoring an upcoming milestone for investors and analysts tracking the health imaging specialist’s performance. The company will accompany the release with a webcast conference call on the same day at 11:00am AEDT, offering stakeholders an opportunity to hear management commentary and gain further insight into operational trends and the company’s positioning in the medical imaging technology market.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$225.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited is an Australian-listed health imaging company that provides advanced medical imaging IT solutions, including radiology information systems and picture archiving and communication systems, to healthcare providers. Listed on the ASX under the ticker PME, the company focuses on delivering technology that supports diagnostic imaging workflows for hospitals and imaging centres.
YTD Price Performance: -8.14%
Average Trading Volume: 176,782
Technical Sentiment Signal: Sell
Current Market Cap: A$21.2B
For an in-depth examination of PME stock, go to TipRanks’ Overview page.